CLINICAL_TRIALS
withdrawal
· 2014-06-06
Clinical Trial Update: Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive Procedures [Phase 3]
Summary
Phase 3 trial evaluating fresh-frozen plasma infusions to reduce bleeding risk during invasive procedures has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Blood Coagulation Disorders | Phase 3 | Status: WITHDRAWN